Skip to main content
Log in

Epoetin alfa in anaemic children or adolescents on regular dialysis

  • Nephrology/Urology
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Eighteen patients aged 5–18 years on regular dialysis had a packed cell volume (PCV)<0.27. On treatment with epoetin alfa (EA) PCV increased by 0.05 or more in all patients. Iron supplementation was necessary in 13 patients with a ferritinaemia <300 μg/l before study. During treatment, plasma potassium increased significantly and more vigorous antihypertensive measures were required in 8 patients, 5 of them being already on antihypertensive drugs before EA. Iliofemoral thrombosis occurred in 1 patient 10 days after renal transplant. The data indicate that EA ameliorates the anaemia of chronic renal disease. The main concerns arising during treatment with EA are hyperkalaemia, arterial hypertension and possibly thrombosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

EA:

epoetin alfa

PCV:

packed cell volume

References

  1. Broyer M, Guillot M, Gubler MC, Habib R (1981) Infantile cystinosis: a rappreisal of early and late symptoms. Adv Nephrol 10: 137–166

    Google Scholar 

  2. Burghard R, Gordjani N, Leititis U (1989) Behandlung der renalen Anämie mit rekombinantem humanen Erythropoietin. Monatsschr Kinderheilkd 137: 174–177

    PubMed  Google Scholar 

  3. Chandra M, McVicar M, Clemons GK (1988) Pathogenesis of the anemia of chronic renal failure: the role of erythropoietin. Adv Pediatr 35: 361–390

    PubMed  Google Scholar 

  4. Edmunds ME, Walls J (1988) Blood pressure and erythropoietin. Lancet 331: 352

    Google Scholar 

  5. Eschbach JW (1989) The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin. Kidney Int 35: 134–148

    PubMed  Google Scholar 

  6. Halpérin DS, Wacker P, Lacourt G, Félix M, Babel JF, Aapro M, Wyss M (1990) Effects of recombinant human erythropoietin in infants with the anemia of prematurity: a pilot study. J Pediatr 116: 779–786

    PubMed  Google Scholar 

  7. Lim VS, De Gowin RL, Zavala D, Kirchner PT, Abels R, Perry P, Fangman J (1989) Recombinant human erythropoietin treatment in pre-dialysis patients: a double blind placebo-controlled trial. Ann Int Med 110: 108–114

    PubMed  Google Scholar 

  8. Mayer G, Thum J, Cada EM, Stummvoll HK, Graf H (1988) Working capacity is increased following recombinant human erythropoietin treatment. Kidney Int 34: 525–528

    PubMed  Google Scholar 

  9. Moia M, Vizzotto L, Cattaneo M, Mannucci PM, Casati S, Ponticelli C (1987) Improvement in the hemostatic defect of uremia after treatment with recombinant human erythropoietin. Lancet 330: 1227–1229

    Article  Google Scholar 

  10. Oetliker OH, Bianchetti MG (1989) Wachstum beim Kind mit nicht dialysepflichtiger Niereninsuffizienz. Schweiz Med Wochenschr 119: 875–880

    PubMed  Google Scholar 

  11. Offner G, Hoyer PF, Latta K, Winkler L, Brodehl J, Scigalla P (1990) One years's experience with recombinant erythropoietin in children undergoing continuous ambulatory or cycling peritoneal dialysis. Pediatr Nephrol 4: 498–500

    Article  PubMed  Google Scholar 

  12. Ponticelli C, Casati S (1989) Correction of anemia with recombinant human erythropoietin. Nephron 52: 201–208

    PubMed  Google Scholar 

  13. Remuzzi G (1989) Bleeding disorders in uremia: pathophysiology and treatment. Adv Nephrol 18: 171–186

    Google Scholar 

  14. Scigalla P, Bonzel KE, Bulla M, Burghard R, Dippel J, Geisert J, Leumann EP, Lilien T van, Müller-Wiefer DE, Offner G, Pistor K, Zoellner K (1989) Therapy of renal anemia with recombinant human erythropoietin in children with end-stage renal disease. Contrib Nephrol 76: 227–241

    PubMed  Google Scholar 

  15. Schäfer RM, Hörl WH, Massry SG (1989) Treatment of renal anemia with recombinant human erythropoietin. Am J Nephrol 9: 353–362

    PubMed  Google Scholar 

  16. Schärer K, Müller-Wiefer DE (1982) Renal anemia in children: a review. Int J Pediatr Nephrol 3: 193–198

    PubMed  Google Scholar 

  17. Schärer K, Brunner FP, Dehn H van, Gurland HJ, Harlen H, Parson FM (1973) Combined report on regular dialysis and transplantation of children in Europe, 1972. Proc Eur Dial Transplant Assoc 10: 58–85

    PubMed  Google Scholar 

  18. Sinai-Trieman L, Saluski IB, Fine RN (1989) Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis. J Pediatr 114: 550–554

    PubMed  Google Scholar 

  19. Weidmann P, Beretta-Piccoli C, Steffen F, Blumberg A, Reubi FC (1976) Hypertension in terminal renal failure. Kidney Int 9: 294–301

    PubMed  Google Scholar 

  20. Winearls CG (1987) Erythropoietin: advent of a new treatment. Practitioner 231: 1269–1273

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bianchetti, M.G., Hämmerli, I., Roduit, C. et al. Epoetin alfa in anaemic children or adolescents on regular dialysis. Eur J Pediatr 150, 509–512 (1991). https://doi.org/10.1007/BF01958435

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01958435

Key words

Navigation